INSURANCE – Adds to existing law to establish provisions regarding coverage of anticancer medications under health benefit plans.

Idaho's H 648 requires health benefit plans covering FDA-approved anticancer medications to treat oral and injected drugs equally for cost-sharing (like copays and deductibles) starting January 1, 2027. This directly affects health insurance plans sold in Idaho that cover anticancer medications, ensuring patients pay the same out-of-pocket costs regardless of whether their medication is taken orally or administered via injection. The bill does not prevent insurers from using formularies, prior authorization, or other standard coverage controls. It specifically applies to medications approved by the FDA for cancer treatment, with the law taking effect July 1, 2026, for implementation.